follow.it gives you an easy way to subscribe to Drug Policy Facts - Knowledge is power's news feed! Click on Follow below and we deliver the updates you want via email, phone or you can read them here on the website on your own news page.
You can also unsubscribe anytime painlessly. You can even combine feeds from Drug Policy Facts - Knowledge is power with other site's feeds!
Title: Drug Policy Facts | Drug Policy Facts
Is this your feed? Claim it!
"Many of the largest one-year declines ever recorded by the study took place across a wide variety of substances during the COVID-19 pandemic between 2020 and 2021. The survey results divide neatly into the time periods before and after the onset of the pandemic. All surveys in 2020 were completed before March 15, when ...
"Classic opioids are natural and synthetic compounds (Platosz et al., 2020; Reisfield et al., 20...
"Although not FDA approved for AUD, the anticonvulsant topiramate can be used for treatment of AUD. Like acamprosate, topiramate is thought to modulate GABA and glutamate transmission. A 2023 meta-analysis of 8 double-blind RCTs (N = 1080) with treatment duration of at least 12 weeks reported a significant reduction in the absolute ...
"Acamprosate, FDA approved for treatment of AUD in 2004, is believed to stabilize the neurochemical imbalance in γ-aminobutyric acid (GABA) and glutamate neurotransmitter systems that develop with sustained heavy alcohol use. Acamprosate is administered as 2 tablets 3 times daily or 1 tablet 3 times daily for a glomerular filtration rate...
"FDA approved for AUD in 1951, disulfiram irreversibly blocks aldehyde dehydrogenase, an important enzyme in the metabolism of alcohol. When patients consume alcohol while taking disulfiram, acetaldehyde rapidly accumulates, causing the disulfiram-ethanol reaction, characterized by nausea, vomiting, headache, flushing, and pal...